,i #aahth ,,congress #ast ,session ,h4 ,r4 #dhhc ,,in ,,the ,,house ,,of ,,representatives ,july #be1 #bjbc ,mr4 ,murphy introduced the following bill2 which was referred to the ,committee on ,ways and ,means1 and in addition to the ,committee on ,energy and ,commerce1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to amend title ,,xviii of the ,social ,security ,act to require the disclosure of certain ownership information relating to health care provider and pharmacy ownership1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,medicare ,common ,ownership ,transparency ,act of #bjbc4 #b4 ,report on integration in ,medicare 7a7 ,required ,,ma and ,,pdp reporting 7#a7 ,,ma plans ,section #aheg7;e7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#bg7;e77 is amended by adding at the end the following new paragraph3 7#f7 ,required disclosure of certain information relating to health care provider ownership 7,a7 ,in general ,for plan year #bjbe and for every third plan year thereafter1 each ,,ma organization offering an ,,ma plan under this part during such plan year shall submit to the ,secretary1 at a time and in a manner specified by the ,secretary-- 7i7 the taxpayer identification number for each health care provider that was a specified health care provider with respect to such organization during such year2 7ii7 the total amount of incentive-based payments made to1 and the total amount of shared losses recoupments collected from1 such specified health care providers during such plan year2 and 7iii7 the total amount of incentive-based payments made to1 and the total amount of shared losses recoupments collected from1 providers of services and suppliers not described in clause 7ii7 during such plan year4 7,b7 ,definition ,for purposes of this paragraph1 the term specified health care provider means1 with respect to an ,,ma organization and a plan year1 a provider of services or supplier with respect to which such organization 7or any person with an ownership or control interest 7as defined in section #aabd7;a77#c77 in such organization7 is a person with an ownership or control interest 7as so defined74 4 7#b7 ,prescription drug plans ,section #ahfj;,d-#ab7;b7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#aab7;b77 is amended by adding at the end the following new paragraph3 7#i7 ,provision of information relating to pharmacy ownership 7,a7 ,in general ,for plan year #bjbe and for every third plan year thereafter1 each ,,pdp sponsor offering a prescription drug plan under this part during such plan year shall submit to the ,secretary1 at a time and in a manner specified by the ,secretary1 the taxpayer identification number and ,national ,provider ,identifier for each pharmacy that was a specified pharmacy with respect to such sponsor during such year4 7,b7 ,definition ,for purposes of this paragraph1 the term specified pharmacy means1 with respect to an ,,pdp sponsor offering a prescription drug plan and a plan year1 a pharmacy with respect to which-- 7i7 such sponsor 7or any person with an ownership or control interest 7as defined in section #aabd7;a77#c77 in such sponsor7 is a person with an ownership or control interest 7as so defined72 or 7ii7 a pharmacy benefit manager offering services under such plan 7or any person with an ownership or control interest 7as so defined7 in such sponsor7 is a person with an ownership or control interest 7as so defined74 4 7b7 ,med,p,a,c reports ,part ,e of title ,,xviii of the ,social ,security ,act 7#db ,u4,s4,c4 #aciex et seq47 is amended by adding at the end the following new section3 #ahii;,c4 ,reports on vertical integration under ,medicare 7a7 ,in general ,not later than ,june #ae1 #bjbi1 and every #c years thereafter1 the ,medicare ,payment ,advisory ,commission shall submit to ,congress a report on the state of vertical integration in the health care sector during the applicable year with respect to entities participating in the ,medicare program1 including health care providers1 pharmacies1 prescription drug plan sponsors1 ,medicare ,advantage organizations1 and pharmacy benefit managers4 ,such report shall include-- 7#a7 with respect to ,medicare ,advantage organizations1 the evaluation described in subsection 7b72 7#b7 with respect to prescription drug plans1 pharmacy benefit managers1 and pharmacies1 the comparisons and evaluations described in subsection 7c72 7#c7 with respect to ,medicare ,advantage plans under which benefits are available for physician-administered drugs1 the information described in subsection 7d72 and 7#d7 the identifications described in subsection 7e72 and 7#e7 an analysis of the impact of such integration on health care access1 price1 quality1 and outcomes4 7b7 ,medicare ,advantage organizations ,for purposes of subsection 7a77#a71 the evaluation described in this subsection is1 with respect to ,medicare ,advantage organizations and an applicable year1 an evaluation1 taking into account patient acuity and the types of areas serviced by such organization1 of-- 7#a7 the average number of qualifying diagnoses made during such year with respect to enrollees of a ,medicare ,advantage plan offered by such organization who1 during such year1 received a health risk assessment from a specified health care provider2 7#b7 the average risk score for such enrollees who received such an assessment during such year2 7#c7 any relationship between such risk scores for such enrollees receiving such an assessment from such a provider during such year and incentive payments made to such providers2 7#d7 the average risk score for enrollees of such plan who received any item or service from a specified health care provider during such year2 7#e7 any relationship between the risk scores of enrollees under such plan and whether the enrollees have received any item or service from a specified provider2 and 7#f7 any relationship between the risk scores of enrollees under such plan that have received any item or service from a specified provider and incentive payments made under the plan to specified providers4 7c7 ,prescription drug plans ,for purposes of subsection 7a77#b71 the comparisons and evaluations described in this subsection are1 with respect to prescription drug plans and an applicable year1 the following3 7#a7 ,for each covered part ,d drug for which benefits are available under such a plan1 a comparison of the average negotiated rate in effect with specified pharmacies with such rates in effect for in-network pharmacies that are not specified pharmacies4 7#b7 ,comparisons of the following3 7,a7 ,the total amount paid by pharmacy benefit managers to specified pharmacies for covered part ,d drugs and the total amount so paid to pharmacies that are not specified pharmacies for such drugs4 7,b7 ,the total amount paid by such sponsors to specified pharmacy benefit managers as reimbursement for covered part ,d drugs and the total amount so paid to pharmacy benefit managers that are not specified pharmacy benefit managers as such reimbursement4 7,c7 ,fees paid under by plan to specified pharmacy benefit managers compared to such fees paid to pharmacy benefit managers that are not specified pharmacy benefit managers4 7#c7 ,an evaluation of the total amount of direct and indirect remuneration for covered part ,d drugs passed through to prescription drug plan sponsors and the total amount retained by pharmacy benefit managers 7including entities under contract with such a manager74 7#d7 ,to the extent that the available data permits1 an evaluation of fees charged by rebate aggregators that are affiliated with plan sponsors4 7d7 ,physician-,administered drugs ,for purposes of subsection 7a77#c71 the information described in this subsection is1 with respect to physician-administered drugs for which benefits are available under a ,medicare ,advantage plan during an applicable year1 the following3 7#a7 ,with respect to each such plan1 an identification of each drug for which benefits were available under such plan only when administered by a health care provider that acquired such drug from an affiliated pharmacy4 7#b7 ,an evaluation of the difference between the total number of drugs administered by a health care provider that were acquired from affiliated pharmacies compared to the number of such drugs so administered that were acquired from pharmacies other than affiliated pharmacies1 and an evaluation of the difference in payments for such drugs so administered when acquired from a specified pharmacy and when acquired from a pharmacy that is not a specified pharmacy4 7#c7 ,an evaluation of the dollar value of all such drugs that were not so administered because of a delay attributable to an affiliated pharmacy compared to the dollar value of all such drugs that were not so administered because of a delay attributable to pharmacy that is not an affiliated pharmacy4 7#d7 ,the number of enrollees administered such a drug that was acquired from an affiliated pharmacy4 7#e7 ,the number of enrollees furnished such a drug that was acquired from a pharmacy that is not an affiliated pharmacy4 7e7 ,identifications ,for purposes of subsection 7a77#d71 the identifications described in this subsection are1 with respect to an applicable year1 identifications of each health care entity participating under the ,medicare program with respect to which another health care entity so participating is a person with an ownership or control interest 7as defined in section #aabd7;a77#c7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acbj;a-#c7;a77#c7774 7f7 ,definitions ,in this section3 7#a7 ,affiliated pharmacy ,the term affiliated pharmacy means1 with respect to a ,medicare ,advantage plan offered by a ,medicare ,advantage organization1 a pharmacy with respect to which such organization 7or any person with an ownership or control interest 7as defined in section #aabd7;a77#c77 in such organization7 is a person with an ownership or control interest 7as so defined74 7#b7 ,applicable year ,the term applicable year means1 with respect to a report submitted under subsection 7a71 the first calendar year beginning at least #d years prior to the date of the submission of such report4 7#c7 ,covered part ,d drug ,the term covered part ,d drug has the meaning given such term in section #ahfj;,d-#b7;e74 7#d7 ,direct and indirect remuneration ,the term direct and indirect remuneration has the meaning given such term in section #dbc4cjh of title #db1 ,code of ,federal ,regulations 7or any successor regulation74 7#e7 ,qualifying diagnosis ,the term qualifying diagnosis means1 with respect to an enrollee of a ,medicare ,advantage plan1 a diagnosis that is taken into account in calculating a risk score for such enrollee under the risk adjustment methodology established by the ,secretary pursuant to section #ahec7;a77#c74 7#f7 ,risk score ,the term risk score means1 with respect to an enrollee of a ,medicare ,advantage plan1 the score calculated for such individual using the methodology described in paragraph 7#e74 7#g7 ,physician-administered drug ,the term physician-administered drug means a drug furnished to an individual that1 had such individual been enrolled under part ,b and not enrolled under part ,c1 would have been payable under section #ahdb7o74 7#h7 ,specified health care provider ,the term specified health care provider means1 with respect to a ,medicare ,advantage plan offered by a ,medicare ,advantage organization1 a health care provider with respect to which such organization 7or any person with an ownership or control interest 7as defined in section #aabd7;a77#c77 in such organization7 is a person with an ownership or control interest 7as so defined74 7#i7 ,specified pharmacy ,the term specified pharmacy means1 with respect to a prescription drug plan offered by a prescription drug plan sponsor1 a pharmacy with respect to which-- 7,a7 such sponsor 7or any person with an ownership or control interest 7as defined in section #aabd7;a77#c77 in such sponsor7 is a person with an ownership or control interest 7as so defined72 or 7,b7 a pharmacy benefit manager offering services under such plan 7or any person with an ownership or control interest 7as so defined7 in such sponsor7 is a person with an ownership or control interest 7as so defined74 7#aj7 ,specified pharmacy benefit manager ,the term specified pharmacy benefit manager means1 with respect to a prescription drug plan offered by a prescription drug plan sponsor1 a pharmacy benefit manager with respect to which such sponsor 7or any person with an ownership or control interest 7as defined in section #aabd7;a77#c77 in such sponsor7 is a person with an ownership or control interest 7as so defined74 4